Source: International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets?
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Maher (St. Albans, United Kingdom). How to better assess and predict disease progression and treatment response: home-based spirometry, biomarkers or …?. International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets?

Member's Comments

No comment yet.

Related content which might interest you: COPD: implementing biomarkers to improve prognosis Source: Virtual Congress 2021 – Clinical year in review Year: 2021 Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation? Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012 Air travel in chronic lung disease: can clinical variables predict response to the hypoxic challenge test? Source: Virtual Congress 2021 – Hypoxia, exercise and respiratory function in pathophysiological conditions Year: 2021 COPD phenotypes and co-morbidities: to what extent do they affect a successful response to rehabilitation? Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 Which clinical variables best predict asthma control? Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control Year: 2010 Is it possible to predict asthma outcomes? A disease model for economic analysis. Source: International Congress 2017 – Asthma management Year: 2017 Can reversibility determine clinical course in patients with COPD? Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 Development of a tool to measure the clinical response to biologic therapy in uncontrolled severe asthma: the FEOS score. Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Can laboratory exercise tests predict the outcome of physical training in patients with severe COPD? Source: Eur Respir J 2002; 20: Suppl. 38, 19s Year: 2002 Spirometry screening in the community: is this an effective way of diagnosing early COPD? Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005 Bronchodilation or pulmonary rehabilitation:which test of exercise performance yields the greatest response for patients with stable COPD? An RCT. Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018 Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)? Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease Source: Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018 Year: 2018 Combined exercise programs in patients with stable COPD: influence of psychological profile and monitoring Source: Eur Respir J 2002; 20: Suppl. 38, 18s Year: 2002 How to manage a patient with COPD - early identification and how to prevent progression Source: ERS Satellites 2021 Year: 2021 Do baseline measurements predict response to treatment in patients with idiopathic hyperventilation? Source: Eur Respir J 2006; 28: Suppl. 50, 864s Year: 2006 COPD patients with low adherence to specific exercise protocols benefit less from rehabilitation Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007 Can lung function predict hypoxic challenge test outcome? Source: Eur Respir J 2007; 30: Suppl. 51, 184s Year: 2007 Improvements in activation for self-management in patients with chronic airway disease via the COPDnet diagnostic trajectory in secondary care; a pilot study. Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018